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Despite global efforts to reduce preventable 
maternal and neonatal mortality, Nigeria’s 
maternal mortality ratio is estimated at 576 
deaths per 100,000 live births and neonatal 
death is estimated at 37 per 1,000 live 
births 1.
Maternal and newborn deaths due to pre-eclampsia and 
eclampsia (PE/E) are preventable, yet in Nigeria this is the most 
significant direct cause of maternal deaths. 
To appreciate the enormity of this problem at country and state 
levels, a landscape analysis was conducted by the Population 
Council in 2015 on PE/E in seven states in Nigeria. The main 
objectives of the landscape analysis were: 
• To understand the level of programmatic and policy 
support for PE/E prevention and treatment;
• To analyze the gaps in providers’ knowledge and 
competence in preventing, detecting, and managing PE/E;
• To determine primary health care (PHC) facilities’ 
capacities to manage PE/E;
• To assess community awareness, beliefs, and experiences 
around PE/E;
• To understand the volume of research on PE/E in the last 
15 years; and
• To determine priority areas for research and programmatic 
interventions around PE/E.
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FINDINGS 
FROM LANDSCAPE 
ANALYSIS IN KOGI ON 
PRE-ECLAMPSIA/ECLAMPSIA
PE/E IN BRIEF
• Pre-eclampsia is a condition               
in pregnant women marked by an 
increase in blood pressure and 
protein in urine after 20 weeks 
gestation.
• Providing high quality antenatal care 
improves the prevention and early 
detection of pre-eclampsia and can 
prevent its progression to eclampsia.
• Eclampsia is a life-threatening 
condition characterized by 
convulsions in women with PE.
• Women in developing countries are 
300 times more likely to die from 
eclampsia than women in developed 
countries.
• Prescribing low-dose aspirin and 
calcium to at-risk women can prevent 
pre-eclampsia and eclampsia.
• Pre-eclampsia and eclampsia can 
be managed by administering anti-
hypertensive drugs and magnesium 
sulphate (MgSO4).
• MgSO4 is the safest and most 
effective treatment for severe PE/E, 
and is one of 13 UN Life-Saving 
Commodities for Women and 
Children. 
• PE/E and other hypertensive 
disorders in pregnancy increase the 
risk of pre-term births, which can 
lead to low birth weight, anemia, and 
stunting.
• Improved prevention, increased 
detection, and effective treatment 
of PE/E can prevent unnecessary 
maternal and newborn deaths.
The Population Council conducts research and delivers 
solutions that improve lives around the world. Big 
ideas supported by evidence: It’s our model for global 
change. popcouncil.org
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The Ending Eclampsia project seeks to expand access                
to proven, underutilized interventions and commodities             
for the prevention, early detection, and treatment of pre-
eclampsia and eclampsia and strengthen global partnerships.
Made possible by the generous support of the 
American people through the United States Agency for 
International Development (USAID).
2FIGURE 1    Proportion of facilities with key 
equipment to detect PE and manage severe PE/E
FACILITY CAPACITY AND 
PREPAREDNESS
To assess institutional preparedness, researchers 
visited eight facilities in Kogi State and recorded that 
only one (13%) of the facilities had guidelines available 
for management of pre-eclampsia, one (13%) had 
all ANC equipment for the detection of PE/E and two 
(25%) use MgSO4 for the treatment of eclampsia. 
During these facility assessments, researchers 
determined whether the facilities had the key ANC 
equipment required to detect pre-eclampsia, manage 
severe PE/E, and monitor for MgSO4 toxicity (figure 1).
Contrary to the facility assessment, four (50%)  facility 
managers reported always using MgSO4 to treat PE/E, 
two (25%) said it is sometimes used, and two (25%) 
reported that it is never used. When asked how they 
obtain MgSO4, 33% of managers said they receive 
it routinely from central supply, half ask clients to 
purchase it and 17% said they procure it elsewhere 
(such as NGOs).
Although hospitals have the capacity to provide signal 
functions for emergency obstetric and neonatal care 
(EmONC), Table 1 shows that PHCs have limited 
capacity for conducting even basic EmONC.
FIGURE 2    Provider knowledge of drugs for PE/E 
prevention and management (n=44)
“You see, the problem here is that 
all these policies are available 
at the national level; but the 
implementers don’t have or see the 
copies.” 
—POLICYMAKER, KOGI
PROVIDER KNOWLEDGE AND 
SKILLS
Providers had good knowledge on signs and symptoms 
of PE (96%) and E (91%), but only 43.2% could correctly 
identify signs and symptoms of chronic hypertension 
and 14% could identify severe PE correctly. 
Researchers also assessed health providers’ 
knowledge of drugs used for preventing and managing 
PE/E as well as calcium gluconate to treat MgSO4 
toxicity (figure 2).
TABLE 1    Signal functions for emergency obstetric 
and newborn care (EmONC)
Figure 2 shows limited provider knowledge on 
prophylactic use of calcium and aspirin for women 
at risk of PE and which anti-hypertensives (aldomet 
or nifedipine) to use for managing high BP during 
pregnancy. The Pritchard regimen for MgSO4 
administration is considered the ‘gold standard’ for 
preventing and treating convulsions in severe PE/E, 
but few providers (16%) could accurately describe the 
appropriate doses of MgSO4 or name the antidote for 
MgSO4 toxicity, calcium gluconate (7%).
3FIGURE 3    Percent of clients who received all 
eight ANC components
in pregnancy. The men also said: to prevent these 
complications, they should encourage their wives to 
register early in their pregnancies for ANC, help them 
with house chores, give them support so they don’t 
‘over think,’ and make them happy all the time. 
Women stated that high blood pressure during 
pregnancy is caused by witchcraft and over thinking, 
adding that it can lead to sleepless nights. One woman 
said that exposure to too much noise can cause 
high blood pressure. Women also discussed seeking 
traditional or spiritual help for high blood pressure from 
herbalists and Imams.
“If you have hypertension,            
the herbalist will tell you                                                        
to do some things, but where                       
there is no money to do it,                          
the high BP will continue.                      
If you go to pray, prayer can help             
a little, but it can’t finish                                     
the high BP. High BP                                      
is the worst sickness in our town.” 
—FEMALE FGD PARTICIPANT, KOGI
Overall, the qualitative findings show that the signs and 
symptoms associated with PE/E are often attributed 
to other causes and community members often 
seek traditional or spiritual healing before medical 
care. Misconceptions, myths, and mistrust between 
communities and health providers negatively influence 
care-seeking behaviors.
SURVIVORS’ EXPERIENCES
Interviews with survivors documented their care-
seeking pathways, including their PE/E experience, 
availability and accessibility of essential services and 
commodities, and the outcomes of the pregnancy 
for mother and child. Survivors’ experiences provide 
insight informing strategies to work more closely with 
communities and health facilities improve access to, 
and use of, quality care. 
The women interviewed were similar in age, ages at 
marriage and first pregnancy, and education. The 
following quotation demonstrates lack of awareness 
and poor health seeking behavior in a young woman 
during her first pregnancy.
QUALITY OF CARE
Quality of care was assessed through observations  of 15 
client-provider interactions and 15 client exit interviews 
with the same pregnant women. Researchers assessed 
eight essential components of quality antenatal care 
(ANC). Figure 3 describes the components that clients 
received.
In addition to the eight essential components of ANC, 
questions and tests should be conducted to assess a 
woman’s risk of developing PE/E, to detect PE/E, and 
inform clients of the signs of impending eclampsia. 
During 75% of the observed ANC consultations, 
providers performed the necessary checks to detect 
women at risk of developing PE. These included history 
of high blood pressure (BP) and diabetes, date of last 
delivery, client’s parity, age and weight, edema of 
face, hands, legs, and ankles. In addition, all providers 
observed in Kogi measured women’s BP and checked 
urine for protein. 
None of the providers, however, advised the clients 
on the symptoms of impending eclampsia (severe 
headache, blurred vision, and pre-eclampsia with 
generalized body swelling).
COMMUNITY KNOWLEDGE 
AND PERCEPTIONS
The study also included in-depth interviews (IDIs) and 
focus group discussions (FGDs) with PE/E survivors, 
community stakeholders, and families affected by 
PE/E. 
Married men reported witchcraft, economic problems, 
fear, death of a loved one, and ‘over thinking’ as 
causes of high blood pressure, swelling, and bleeding 
“I am 17 years old, and I 
was married two years ago.                
This is my first pregnancy.                
I never attended ANC before,              
but I came to the hospital when 
I had a severe headache for 
over two weeks, I became dizzy                  
and fell down. I went to a hospital. 
I didn’t know what happened,       
but later the doctor told me                          
that my BP was 250/150.                           
I am OK now, but lost my baby.”  
—PE/E SURVIVOR, KOGI
DISCUSSION & CONCLUSION
This landscape analysis identified the gaps in facilities’ 
and providers’ capacities for preventing, detecting, and 
managing PE/E; it assessed community awareness, 
beliefs, and experiences of PE/E; and it determined the 
gaps and priority areas for research and programs to 
improve access to prevention and treatment. 
It is clear, at the state policy level, that there is limited 
knowledge of what has been developed nationally; 
there is confusion about how policies, guidelines, and 
protocols reach not only the states but also the facilities 
themselves, where they don’t seem to exist at all.
For effective PE/E management, health facilities 
need to stock necessary drugs and ANC equipment, 
and institutionalize guidelines for PE/E treatment. 
Researchers noted irregular supply of basic drugs, 
equipment, and supplies, particularly MgSO4, patella 
hammers and the MgSO4 antidote, calcium gluconate, 
which no facilities stocked. 
Providers’ knowledge is generally poor in Kogi; health 
care providers need to be trained and re-trained on PE 
prevention—including when to administer prophylactic 
drugs such as calcium supplements and aspirin—and 
its early detection, and how and when to administer 
anti-hypertensives and MgSO4 for early treatment of 
the condition. 
In addition to ensuring providers are adequately trained 
to administer MgSO4 at the right time, and with the 
proper doses, they also need to know the warning signs 
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for MgSO4 toxicity and its antidote, calcium gluconate. 
There is also limited capacity for newborn resuscitation.
The final, essential component to reduce mortality from 
PE/E is community awareness. Community members 
need to know the signs of PE/E and understand the 
danger it poses for mothers and babies so they can 
seek medical care promptly.
A multi-pronged approach is required to address 
the systems issues that create barriers to women’s 
access to health care during pregnancy. Detecting and 
managing PE/E early can improve the survival rate in 
women and babies in Nigeria.
RECOMMENDATIONS
• Advocacy for streamlining state procurement and 
link to a national or central distribution system;
• Connecting with United Nations Commission on 
Life-Saving Commodities (UNCoLSC) for Women 
and Children, especially for maternal drugs which 
include MgSO4;
• Training on quality ANC: what, why, how, when and 
where;
• Introduce task-shifting policy focusing on MNH 
“policy implementation plan” to include anti-
hypertensives and MgSO4;
• Train PHC workers to detect and provide loading 
dose of MgSO4;
• Community awareness campaigns on the 
importance of ANC and seeking care early; and
• Engage men to encourage their support of their 
wives.
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